To narrow your search, use one or more of the following search menus below.
June 8, 2021
JCI insight
Cruz-Herranz, A;Oertel, FC;Kim, K;Cantó, E;Timmons, G;Sin, JH;Devereux, M;Baker, N;Michel, B;Schubert, RD;Rani, L;Cordano, C;Baranzini, SE;Green, AJ;
Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer
In vivo retinal monitoring in EAE
Mice. For experiments involving in vivo retinal imaging, CX3CR1GFP/+–knock-in mice were fully backcrossed into C57BL/6J. We confirmed the absence of an RD8 mutation (associated with hereditary macular degeneration). In CX3CR1GFP/+–knock-in mice, microglia, macrophages, monocytes, and NK cells express GFP, which can be imaged through CSLO (14), without any immunologic alterations (15).
Induction and clinical scoring of MOG35-55 EAE. Seven female mice at 10 weeks of age were immunized s.c. with 100 μg of MOG35–55 peptide (Genemed Synthesis) in complete Freund’s adjuvant containing 400 μg Mycobacterium tuberculosis H37Ra (Difco Laboratories). Mice received 200 ng pertussis toxin (List Biological) by i.p. injection at the time of and after immunization. We monitored clinical scores, as described before (42). …
Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
• Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
• Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
• Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)
June 7, 2021
The Journal Of Experimental Medicine
Vijay, R;Guthmiller, JJ;Sturtz, AJ;Crooks, S;Johnson, JT;Li, L;Lan, LY;Pope, RL;Chen, Y;Rogers, KJ;Dutta, N;Toombs, JE;Wilson, ME;Wilson, PC;Maury, W;Brekken, RA;Butler, NS;
Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis
… anthrax protective antigen (recombinant from Bacillus anthracis; 0.5 µg/ml; List Biological Laboratories, Inc.), …
• Product #171E – Anthrax Protective Antigen (PA), Recombinant from B. anthracis
June 5, 2021
Journal of Neuroinflammation
Une, H;Yamasaki, R;Nagata, S;Yamaguchi, H;Nakamuta, Y;Indiasari, UC;Cui, Y;Shinoda, K;Masaki, K;Götz, M;Kira, JI;
Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer
Induction and clinical evaluation of EAE
We induced EAE by immunization of mice with 4 mg/ml MOG35–55 peptide (TS-M704-P; MBL, Nagoya, Japan) emulsified in complete Freund’s adjuvant containing 1 mg/ml Mycobacterium tuberculosis H37RA (#231131; BD Difco, Lawrence, KS, USA) at a dose of 200 μg per mouse, followed by intraperitoneal injections of 300 ng pertussis toxin (# 180-A1; List Biological Laboratories Inc., Campbell, CA, USA) per mouse on days 0 and 2. …
• Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
June 3, 2021
International Immunopharmacology
Zhao, P;Chen, X;Han, X;Wang, Y;Shi, Y;Ji, J;Lei, Y;Liu, Y;Kong, Q;Mu, L;Wang, J;Zhao, W;Wang, G;Liu, X;Zhang, T;Zhang, Y;Sun, B;Liu, Y;Li, H;
Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer
2.2. Induction and evaluation of EAE
The EAE inducing antigen employed was myelin oligodendrocyte glycoprotein peptide (MOG35-55). To induce EAE, complete Freund’s adjuvant (CFA) emulsified with an equal volume of phosphate-buffered saline (PBS) containing 250 µg of Mycobacterium tuberculosis strain H37Ra (BD Biosciences, San Jose, CA, USA) and 200 µg of MOG35–55 (MEVGWYRSPFSRVVHLYRNGK) (Wuhan Bioyears gene Biotechnology Inc., China), was injected into the mice subcutaneously in each axillary fossa, on experimental day 0 and day 2, immediately followed by an intravenous injection of pertussis toxin (200 ng, List Biological Laboratories, Inc., Campbell, CA, USA) in the tail vein. The control group received only CFA in place of the EAE induction solution. …
Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
• Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
• Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
• Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)
June 3, 2021
Science
Cugurra, A;Mamuladze, T;Rustenhoven, J;Dykstra, T;Beroshvili, G;Greenberg, ZJ;Baker, W;Papadopoulos, Z;Drieu, A;Blackburn, S;Kanamori, M;Brioschi, S;Herz, J;Schuettpelz, LG;Colonna, M;Smirnov, I;Kipnis, J;
Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer
… Mice received 200 ng of pertussis toxin (List Biological Laboratories) IP on day 0 (immunization day) and day 1 (24 hours after immunization). …
Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
• Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
• Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
• Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)
June 2, 2021
Research Square
Cornejo, M;Denis, R;Romero, G;Fernandez, G;Reynaldo, M;Luquet, S;Perello, M;
Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae
2.2 Drugs
… Diphtheria toxin (List Biological Laboratories) was dissolved in saline and administered at 50 mg/kg, based on previous reports …
• Product #150 – Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae
June 2, 2021
Microorganisms
Smith, K;Garman, L;Norris, K;Muther, J;Duke, A;Engler, RJM;Nelson, MR;Collins, LC;Spooner, C;Guthridge, C;James, JA;
Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis
2.3. LT Neutralization Activity (LTNA)
Recombinant PA and LF were purchased from List Biological (List Biological Laboratories Inc., Campbell, CA, USA). The ability of participant plasma to neutralize LT (LTNA) was adapted from the standard procedure from the CDC as previously described [29] using the J774.1 macrophage cell line (ATCC, Manassas, VA, USA). In brief, cells were plated overnight at 90,000 cells/well in a 96-well plate. Plasma samples were diluted 1:50 in culture medium, and then diluted for eight additional serial two-fold dilutions in dilution tubes, and then incubated with LT for 30 min at 37 °C (600 ng/mL of PA, 120 ng/mL of LF) before adding to cell cultures. Control wells included cells alone, cells with added PA only, LF only, or cells with PA and LF (LT). …
• Product #171E – Anthrax Protective Antigen (PA), Recombinant from B. anthracis
Author did not specify which Lethal Factor (LF) was utilized; List Labs provides the following LF:
• Prodcut #172 – Anthrax Lethal Factor (LF), Recombinant from B. anthracis
• Product #169L – Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence
June 2, 2021
Frontiers In Immunology
Na, SY;Krishnamoorthy, G;
Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer
EAE Induction
Mice were injected s.c. at the tail base with an emulsion containing equal amounts of complete Freund’s adjuvant (CFA) (Difco) containing 5 mg/ml Mycobacterium tuberculosis (strain H37Ra) (Difco) and 200 µg MOG35-55 in PBS. 400 ng of pertussis toxin (List Biological Labs) was injected i.p. on days 0 and 2 following immunization. …
Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
• Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
• Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
• Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)
June 1, 2021
Vaccines
Komla, E;Torres, OB;Jalah, R;Sulima, A;Beck, Z;Alving, CR;Jacobson, AE;Rice, KC;Matyas, GR;
Product: Diphtheria Toxoid, from Corynebacterium diphtheriae
2.1. Materials and Reagents
… Diphtheria toxoid (DT), pertussis toxin (PT), and TT used as coating antigens for ELISA were purchased from List Biological Laboratories, Inc. (Campbell, CA, USA). …
• Product #151 – Diphtheria Toxoid, from Corynebacterium diphtheriae
• Product #190 – Tetanus Toxin from Clostridium tetani
Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
• Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
• Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
• Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)
June 1, 2021
Journal For Immunotherapy Of Cancer
Kim, BS;Kuen, DS;Koh, CH;Kim, HD;Chang, SH;Kim, S;Jeon, YK;Park, YJ;Choi, G;Kim, J;Kang, KW;Kim, HY;Kang, SJ;Hwang, S;Shin, EC;Kang, CY;Dong, C;Chung, Y;
Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae
Mice
C57BL/6 mice were either home-bred or were purchased from SamTako Ltd (South Korea). B6.SJL, Pmel Tg , Il17a Cre mice were purchased from Jackson Laboratory. Foxp3 DTR mice were kindly provided by Dr. Sin-Hyeog Im (POSTECH) with the permission of Dr. Alexander Rudensky (Memorial Sloan Kettering Cancer Center).23 R26 DTA mice and R26 YFP mice were previously described.24 25 Il17a Cre ×R26 YFP , Il17a Cre ×R26 DTA, and Il17a Cre ×R26 DTA/YFP mouse systems were created by breeding the relevant strains. CCSP Cre ×K-ras G12D mice have been described.7 Male or female mice of 8–12 weeks were used, and each experiment was conducted using age-matched/sex-matched groups. For DTR-mediated depletion experiments, 500 µg of diphtheria toxin (List Biological Laboratories) was intraperitoneally treated every other day after tumor injection in Foxp3 DTR mouse systems. …
• Product #150 – Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae